-
公开(公告)号:US20210024896A1
公开(公告)日:2021-01-28
申请号:US16981455
申请日:2019-03-28
Applicant: Osaka University
Inventor: Kohji Nishida , Ryuhei Hayashi , Toru Okubo , Yoichi Honma
Abstract: Provided is a method for producing a stem cell-derived lacrimal gland tissue, the method comprising isolating SSEA4 and CD104 double positive cells from a self-formed ectodermal autonomous multi-zone (SEAM) cell population derived from pluripotent stem cells and three-dimensionally culturing the isolated cells in a medium with epidermal growth factor (EGF) and a ROCK inhibitor to produce a cell population expressing a lacrimal gland-related protein. The present invention provides a lacrimal gland organoid produced from pluripotent stem cells including iPS cells and thus is very useful for cell-based regenerative therapy for lacrimal gland-related diseases and cell-based research on the diseases.
-
公开(公告)号:US20200010800A1
公开(公告)日:2020-01-09
申请号:US16482160
申请日:2018-01-31
Applicant: Osaka University
Inventor: Kohji Nishida , Kiyotoshi Sekiguchi , Ryuhei Hayashi , Shun Shibata
IPC: C12N5/079
Abstract: The present invention relates to a method for controlling differentiation of pluripotent stem cells, which method comprises selecting a laminin or a fragment thereof based on binding affinity for the pluripotent stem cells and inducing differentiation of the pluripotent stem cells in the presence of the laminin or a fragment thereof. Here, the binding affinity for cells can be assessed by time-course observation of the survival rate and motility of the cells. According to the present invention, a cell population containing any desired proportion of differentiated cells can be produced from pluripotent stem cells in a simple manner. The cell population obtained by this production method is very useful for cell therapy-based treatment strategies for diseases.
-
3.
公开(公告)号:US11066641B2
公开(公告)日:2021-07-20
申请号:US15542200
申请日:2016-01-13
Applicant: Osaka University
Inventor: Kohji Nishida , Ryuhei Hayashi , Yuki Ishikawa
Abstract: The present invention relates to a method for inducing the differentiation of corneal epithelial cells from pluripotent stem cells. More specifically, the present invention relates to a method for autonomously differentiating pluripotent stem cells, such as human iPS cells, into ectodermal cell lineage in a serum-free medium without using feeder cells and inducing the differentiation of the resultant ocular surface ectodermal lineage cells into corneal epithelial cells.
-
4.
公开(公告)号:US20150351380A1
公开(公告)日:2015-12-10
申请号:US14416148
申请日:2013-07-03
Applicant: OSAKA UNIVERSITY
Inventor: Ryuhei Hayashi , Kohji Nishida , Ryosuke Katori
IPC: A01N1/02
CPC classification number: A01N1/0226
Abstract: The present invention provides a tissue preservation solution that has good quality for preservation of tissues, organs and cells, and is useful in the fields of regenerative medicine, transplantation medicine, etc. The tissue preservation solution of the present invention comprises a compound having a Nrf2 activating effect. Preferable compounds having a Nrf2 activating effect are electrophiles, and in particular, ebselen and tert-butylhydroquinone. A preferable basal solution of the tissue preservation solution is Hank's balanced salt solution.
Abstract translation: 本发明提供一种保存组织,器官和细胞的良好质量的组织保存液,可用于再生医学,移植药物等领域。本发明的组织保存液含有具有Nrf2 激活效果。 具有Nrf2活化作用的优选化合物是亲电子试剂,尤其是依普硒和叔丁基氢醌。 组织保存液的优选基础溶液是汉克平衡盐溶液。
-
5.
公开(公告)号:US12247219B2
公开(公告)日:2025-03-11
申请号:US17348174
申请日:2021-06-15
Applicant: Osaka University
Inventor: Kohji Nishida , Ryuhei Hayashi , Yuki Ishikawa
Abstract: The present invention relates to a method for inducing the differentiation of corneal epithelial cells from pluripotent stem cells. More specifically, the present invention relates to a method for autonomously differentiating pluripotent stem cells, such as human iPS cells, into ectodermal cell lineage in a serum-free medium without using feeder cells and inducing the differentiation of the resultant ocular surface ectodermal lineage cells into corneal epithelial cells.
-
公开(公告)号:US11649433B2
公开(公告)日:2023-05-16
申请号:US16482160
申请日:2018-01-31
Applicant: Osaka University
Inventor: Kohji Nishida , Kiyotoshi Sekiguchi , Ryuhei Hayashi , Shun Shibata
IPC: A61K35/545 , C12N5/079 , A61K38/18
CPC classification number: C12N5/0621 , A61K35/545 , A61K38/1825 , A61K38/18 , C12N2501/998 , C12N2506/45 , C12N2533/52
Abstract: The present invention relates to a method for controlling differentiation of pluripotent stem cells, which method comprises selecting a laminin or a fragment thereof based on binding affinity for the pluripotent stem cells and inducing differentiation of the pluripotent stem cells in the presence of the laminin or a fragment thereof. Here, the binding affinity for cells can be assessed by time-course observation of the survival rate and motility of the cells. According to the present invention, a cell population containing any desired proportion of differentiated cells can be produced from pluripotent stem cells in a simple manner. The cell population obtained by this production method is very useful for cell therapy-based treatment strategies for diseases.
-
公开(公告)号:US20210332324A1
公开(公告)日:2021-10-28
申请号:US16476521
申请日:2017-12-27
Applicant: Osaka University
Inventor: Kohji Nishida , Ryuhei Hayashi , Shun Shibata
Abstract: The present invention provides a method for producing a corneal epithelial cell population for the fabrication of corneal epithelial cell sheets for transplantation, the method comprising the steps of: (1) preparing a cell population containing corneal epithelial cells; (2) subjecting the cell population prepared in step (1) to magnetic-activated cell sorting and collecting CD200-negative/SSEA-4-positive cells; and (3) bringing the cells collected in step (2) into contact with a laminin selected from the group consisting of a laminin having an α3 chain, a laminin having an α4 chain and a laminin having an α5 chain, or an E8 fragment thereof, and collecting cells adherent thereto.
-
8.
公开(公告)号:US20210207087A1
公开(公告)日:2021-07-08
申请号:US17057021
申请日:2019-05-22
Applicant: Osaka University
Inventor: Kohji Nishida , Ryuhei Hayashi , Kimihito Nomi
Abstract: Provided is a method for inducing differentiation into conjunctival epithelial cells, conjunctival goblet cells, and conjunctival epithelial stem and progenitor cells, the method comprising culturing colonies of pluripotent stem cells in a medium containing an epidermal growth factor (EGF) signaling activator to induce differentiation of the pluripotent stem cells. The present invention enables differentiation of pluripotent stem cells including iPS cells into conjunctival epithelial cells, conjunctival goblet cells, and conjunctival epithelial stem and progenitor cells and therefore is very useful for, for example, basic research on conjunctival epithelial cells and conjunctival goblet cells, regenerative therapy for intractable ocular surface diseases, and research related to the diseases.
-
公开(公告)号:US20190390274A1
公开(公告)日:2019-12-26
申请号:US16480938
申请日:2018-01-26
Applicant: Osaka University
Inventor: Kohji Nishida , Ryuhei Hayashi , Toru Okubo
IPC: C12Q1/6881
Abstract: An object of the present invention is to provide a method for determining anatomical sites of a body surface tissue. Provided is a method for determining an anatomical site of origin of a body surface tissue specimen, the method comprising the steps of:(A) selecting at least 8 kinds of genes from the group consisting of a Hox gene family and a Pax6 gene; (B) measuring the expression levels of the genes selected in the above (A) in the body surface tissue specimen; and (C) determining the anatomical site of origin of the body surface tissue specimen based on the expression levels or a combination of the expression levels measured in the above (B).
-
公开(公告)号:US10457913B2
公开(公告)日:2019-10-29
申请号:US15543021
申请日:2016-01-12
Applicant: Osaka University
Inventor: Kohji Nishida , Yuzuru Sasamoto , Ryuhei Hayashi
Abstract: The present invention relates to a method for inducing a keratin 12-positive corneal epithelioid cell from a surface ectoderm-derived cell. More specifically, the present invention relates to a method for inducing a keratin 12-positive corneal epithelioid cell, comprising introducing PAX6, KLF4, and OCT4 into a surface ectoderm-derived cell, such as an oral mucosal epithelial cell, and a corneal epithelioid cell induced by the method.
-
-
-
-
-
-
-
-
-